Novel transcript, antisense to ACAT1 (ENSG00000285696)

The "novel transcript, antisense to ACAT1" (ENSG00000285696) is a non-protein-coding RNA transcribed antisense (opposite) to the ACAT1 gene locus[1]. Natural antisense transcripts such as this are widespread in the genome and are involved in regulating expression of their sense counterparts via mechanisms that may include transcriptional interference, chromatin modification, transcript stability modulation, and epigenetic regulation[6][7]. The functional outcome of antisense transcription can involve decreased production or altered stability of the sense transcript, which for this locus would affect ACAT1, an enzyme important for mitochondrial metabolism and ketone processing[5][2][4][6][7]. No direct disease associations or therapeutic interactions have been characterized for this specific transcript as of current knowledge[1][3]. This entry is best classified as a regulatory non-coding RNA, not a classical drug target, and should not be treated as a protein-coding receptor, enzyme, or similar therapeutic target class.

Not applicable; not a protein-coding target; possible gene expression modulation by RNA interference or chromatin modification